![Christine Dolan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 3 M $ in data 31/07/2026
Christine Dolan is EVP & General Manager-Cygnus Technologies at Maravai Lifesciences Holdings, Inc. since 2024.
Former roles include Director-Nuclear Operations & Global Quality at Amersham Health, Director-Nuclear Operations & Global Quality at GE Healthcare, Inc. from 2008 to 2009, and Senior Vice President-Product Development at Catalent, Inc. from 2016 to 2017.
Education includes undergraduate studies at Lenoir-Rhyne University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/05/2026 | 425.318 ( 0,29% ) | 3 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Corporate Officer/Principal | 27/07/2023 |
| Società | Posizione | Fine |
|---|---|---|
| CATALENT, INC. | Corporate Officer/Principal | 01/10/2017 |
GE Healthcare, Inc.
 GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Corporate Officer/Principal | 01/09/2009 |
Amersham Health | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Lenoir-Rhyne University
 Lenoir-Rhyne University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amersham Health | |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Health Technology |
Catalent, Inc.
 Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Maravai Lifesciences Holdings, Inc.
 Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
